Health
Antiviral proves effective at preventing, treating COVID-19 in lab – EurekAlert
Publishing their work in Nature, scientists at the UNC School of Medicine and UNC Gillings School of Global Public Health tested how the orally administered experimental…
CHAPEL HILL, NC – Publishing their work in Nature, scientists at the UNC School of Medicine and UNC Gillings School of Global Public Health found that the orally administered experimental drug EIDD-2801 halts SARS-CoV-2 replication and prevents infection of human cells in a new in vivo lab model containing human lung tissue.
Separate phase 2 and 3 clinical trials are ongoing to evaluate EIDD-2801 safety in humans and its effect on viral shedding in COVID-19 patients.
The number of new COVID-19…
-
Noosa News21 hours agoQueensland GP accused of rape, sexual assault and torture pleads for bail despite ‘disturbing’ allegations
-
General13 hours agoCoalition to chart path forward as family feud cooled
-
General21 hours agoDavid Littleproud’s own goal • Inside Story
-
General10 hours agoStar Wars’ fascist dystopia has never felt closer than in new season of Andor